Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

IQVIA Holdings, Inc. Common Stock (NY:IQV)

182.34 -1.40 (-0.76%)
Streaming Delayed Price Updated: 11:08 AM EDT, Sep 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about IQVIA Holdings, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
IQVIA Announces CFO Transition in Early 2026
From IQVIA Holdings Inc.
Via Business Wire
Veeva Systems Lifts Outlook on CRM Wins
Via The Motley Fool
Topics Artificial Intelligence
Firefly Stock Jumps As Nvidia Partnership Boosts AI-Driven EEG Technology For Neurological Care
Firefly Neuroscience (AIFF) stock up after unveiling CLEAR Platform powered by Nvidia's (NVDA) L40S GPU for improved EEG data quality and processing speed. 
Via Benzinga
Integer Holdings, Astrana Health, Surgery Partners, IQVIA, and Supernus Pharmaceuticals Shares Skyrocket, What You Need To Know
A number of stocks jumped in the afternoon session after the major indices rebounded, as Fed Chair Jerome Powell delivered dovish remarks at the much-awaited Jackson Hole symposium. Powell suggested... 
Via StockStory
Topics Economy
Where IQVIA Hldgs Stands With Analysts
 
Via Benzinga
Integra LifeSciences, IQVIA, Avantor, National Vision, and United Airlines Shares Plummet, What You Need To Know
A number of stocks fell in the morning session after markets continued to decline, as investors grew cautious ahead of a key speech by Federal Reserve Chair Jerome Powell. 
Via StockStory
Topics Economy Stocks
Q2 Earnings Highs And Lows: IQVIA (NYSE:IQV) Vs The Rest Of The Drug Development Inputs & Services Stocks
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how drug development inputs & services stocks fared in Q2,... 
Via StockStory
IQVIA and Veeva Announce Long-term Clinical and Commercial Partnerships and Resolution of All Disputes
From IQVIA
Via Business Wire
Preview: IQVIA Hldgs's Earnings
 
Via Benzinga
David Tepper's Hedge Fund Bets On Intel, UnitedHealth; Cuts Position In Four Mag 7 Stocks
David Tepper sold casino stocks and bought airline stocks in the second quarter. Here's a look at the changes made to the Appaloosa hedge fund. 
Via Benzinga
1 Cash-Producing Stock for Long-Term Investors and 2 We Question
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. 
Via StockStory
Thermo Fisher, ICU Medical, CONMED, Pediatrix Medical Group, and IQVIA Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after positive inflation data fueled hopes for an interest rate cut by the Federal Reserve. The latest Consumer Price Index (CPI) report showed... 
Via StockStory
Topics Bonds Economy Government
1 Large-Cap Stock to Research Further and 2 We Ignore
Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit growth as expanding further becomes an... 
Via StockStory
Thermo Fisher, Baker Hughes And IQVIA Holdings Are Among Top 10 Large Cap Gainers Last Week (July 21-July 25): Are The Others In Your Portfolio?
Medpace, ICON, and West Pharma led last week's large-cap rally, driven by strong earnings beats and upgraded guidance. 
Via Benzinga
Topics Earnings
Why IQVIA (IQV) Stock Is Up Today
Shares of clinical research company IQVIA (NYSE: IQV) jumped 3% in the afternoon session on continued positive momentum after the company reported better-than-expected second-quarter earnings and... 
Via StockStory
IQV Q2 Deep Dive: AI Initiatives and Pipeline Growth Drive Outperformance Amid Margin Pressures
Clinical research company IQVIA (NYSE: IQV) announced better-than-expected revenue in Q2 CY2025, with sales up 5.3% year on year to $4.02 billion. The company’s full-year revenue guidance of $16.2... 
Via StockStory
Topics Artificial Intelligence
Explore the top gainers and losers within the S&P500 index in today's session.
Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Tuesday. 
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Intraday Session
 
Via Benzinga
Discover which S&P500 stocks are making waves on Tuesday.
Let's delve into the developments on the US markets in the middle of the day on Tuesday. Below, you'll find the top gainers and losers within the S&P500 index during today's session. 
Via Chartmill
Lockheed, General Motors Tumble, Gold Hits 1-Month Highs: What's Moving Markets Tuesday?
It was a quiet Tuesday on Wall Street, as major indexes edged lower with investors pausing ahead of a critical wave of tech earnings. 
Via Benzinga
Why IQVIA (IQV) Stock Is Trading Up Today
Shares of clinical research company IQVIA (NYSE: IQV) jumped 15.9% in the morning session after the company reported second-quarter financial results that beat Wall Street expectations and raised its... 
Via StockStory
Topics Artificial Intelligence
Tuesday's session: gap up and gap down stock in the S&P500 index
Let's have a look at the S&P500 gap up and gap down stocks in today's session. 
Via Chartmill
D.R. Horton, IQVIA Holdings, Northrop Grumman And Other Big Stocks Moving Higher On Tuesday
 
Via Benzinga
Iqvia Surges As 'Pluses' Outweigh 'Minuses' In Its Second-Quarter Report
Iqvia stock surged Tuesday after the clinical resource organization widely beat most second-quarter metrics. 
Via Investor's Business Daily
Topics Government
Tuesday's pre-market session: top gainers and losers in the S&P500 index
Before the opening bell on Tuesday, let's take a glimpse of the US markets and explore the S&P500 top gainers and losers in today's pre-market session. 
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga
IQVIA (NYSE:IQV) Beats Q2 Sales Targets, Stock Soars
Clinical research company IQVIA (NYSE: IQV) reported Q2 CY2025 results topping the market’s revenue expectations, with sales up 5.3% year on year to $4.02 billion. The company’s full-year revenue... 
Via StockStory
IQVIA Reports Second-Quarter 2025 Results
From IQVIA Holdings Inc.
Via Business Wire
IQVIA Earnings: What To Look For From IQV
Clinical research company IQVIA (NYSE: IQV) will be reporting earnings this Tuesday before the bell. Here’s what you need to know. 
Via StockStory
Topics Artificial Intelligence
Earnings Scheduled For July 22, 2025
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.